Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription 09.02.2026 4 Ann Intern Med 2 BMJ 4 Clin Infect Dis 1 J Gen Virol 1 J Immunol 1 J Infect Dis 3 JAMA 1 Nat Immunol 1 Nat Med 1 Pediatr Infect Dis J 1 Pediatrics 7 PLoS One 3 Science 28 Vaccine 2 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
   Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
   PubMed         Abstract available
   
   
2. 
   Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
   PubMed        
   
   
3. STENSBALLE LG
   Context Matters: Comparing the United States and Denmark in Vaccine-Preventable Disease Risk.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-26-00249.
   PubMed        
   
   
4. WENTZENSEN N, Egemen D
   Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
   PubMed        
   
   

   
   BMJ

5. TANNE JH
   RFK Jr names anti-vaccine members to federal autism committee.
   BMJ. 2026;392:s216.
   PubMed        
   
   
6. LOGAN M
   Trump to withhold Gavi funding until all vaccines with mercury removed.
   BMJ. 2026;392:s208.
   PubMed        
   
   

   
   Clin Infect Dis

7. AABY P, Biering-Sorensen S, Lund N, Jensen KJ, et al
   Misleading comments about the impact of early BCG vaccination on neonatal and infant mortality.
   Clin Infect Dis. 2026 Feb 4:ciag065. doi: 10.1093.
   PubMed        
   
   
8. MA KC, Surie D, Dean N, Paden CR, et al
   Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness.
   Clin Infect Dis. 2026 Feb 2:ciag059. doi: 10.1093.
   PubMed         Abstract available
   
   
9. MAYER EF, Falsey AR, Clark R, Ferguson M, et al
   Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.
   Clin Infect Dis. 2026;81:e708-e716.
   PubMed         Abstract available
   
   
10. DAGAN R, van der Beek BA, Grupel T, Greenberg D, et al
    Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel.
    Clin Infect Dis. 2026;81:e690-e699.
    PubMed         Abstract available
    
    

    
    J Gen Virol

11. SABSABI MA, Kheimar A, von La Roche D, Hartle S, et al
    Role of gammadelta T cells in turkey herpesvirus vaccine protection against Marek's disease virus.
    J Gen Virol. 2026;107:002204.
    PubMed         Abstract available
    
    

    
    J Immunol

12. LI J, Simonson AW, Flynn JL
    CD8+ lymphocytes in immunity against tuberculosis.
    J Immunol. 2025 Oct 10:vkaf268. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

13. KESKIN PB
    Comment on B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients.
    J Infect Dis. 2026 Feb 2:jiag055. doi: 10.1093.
    PubMed        
    
    

    
    JAMA

14. ANDERER S
    High-Dose Flu Vaccine Demonstrates Benefits in Older Adults With Diabetes.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26366.
    PubMed        
    
    
15. ABBASI J
    Mechanisms Are Emerging for COVID-19 Vaccine-Associated Myocarditis.
    JAMA. 2026 Feb 6. doi: 10.1001/jama.2025.25866.
    PubMed        
    
    
16. ANDERER S
    Vaccinations Dip Among Older Adults.
    JAMA. 2026 Feb 6. doi: 10.1001/jama.2025.26382.
    PubMed        
    
    

    
    Nat Immunol

17. BLANCO J
    Better and closer glycan-independent anti-V3 antibodies to help HIV-1 vaccine.
    Nat Immunol. 2026 Feb 3. doi: 10.1038/s41590-025-02409.
    PubMed        
    
    

    
    Nat Med

18. WEISOVA P, Scheiblauer S, Ecker J, Schneider M, et al
    Live-attenuated chikungunya vaccine in children: a randomized phase 2 trial.
    Nat Med. 2026 Feb 6. doi: 10.1038/s41591-025-04197.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

19. SAEZ-LLORENS X, DeAntonio R
    Recent Advances in Dengue Vaccines for Children: Current Evidence and Future Directions.
    Pediatr Infect Dis J. 2026 Feb 2. doi: 10.1097/INF.0000000000005172.
    PubMed        
    
    

    
    Pediatrics

20. ULRICH AK, Fleming DF, Smith EA, Anderson CJ, et al
    Hepatitis B Vaccination at Birth: Safety, Effectiveness, and Public Health Benefit.
    Pediatrics. 2026 Feb 5. doi: 10.1542/peds.2025-075783.
    PubMed         Abstract available
    
    

    
    PLoS One

21. MA H, Tatum FM, Briggs RE, Dassanayake RP, et al
    Transcriptome profiling indicates varied gene responses to Pasteurella multocida mutant infections in cattle.
    PLoS One. 2026;21:e0341813.
    PubMed         Abstract available
    
    
22. MOI F, Nguyen VM, Archer R, Namalela T, et al
    The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries.
    PLoS One. 2026;21:e0341964.
    PubMed         Abstract available
    
    
23. ARKOK HS, Wahyono TYM, Aldila D, Prihartono NA, et al
    Modeling HBV transmission dynamics in Indonesia (2024-2030) using a SIVRM model: Evaluating optimal control strategies for elimination by 2030.
    PLoS One. 2026;21:e0341120.
    PubMed         Abstract available
    
    
24. KIM S, Kim K
    Combined association of socioeconomic status and type 2 diabetes with influenza vaccination in older adults: A cross-sectional analysis of the Korea National Health and Examination Survey (2019-2022).
    PLoS One. 2026;21:e0341831.
    PubMed         Abstract available
    
    
25. DINERO RE, Monti WB, Kmush BL
    Regional political climate's moderating role in the association between political conservatism and COVID-19 vaccine hesitancy in the United States.
    PLoS One. 2026;21:e0342063.
    PubMed         Abstract available
    
    
26. EDAE CK, Bedada AT, Teklemariam MD, Tolesa MB, et al
    A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia.
    PLoS One. 2026;21:e0340457.
    PubMed         Abstract available
    
    
27. AGYARE G, Courtin D, Asamoah Sakyi S, Nakotey GK, et al
    Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens.
    PLoS One. 2026;21:e0341659.
    PubMed         Abstract available
    
    

    
    Science

28. BANNARD O, Howarth MR
    A double helix twist in HIV vaccine design.
    Science. 2026;391:553-554.
    PubMed         Abstract available
    
    
29. CHANDRASHEKHAR V
    Side effects dim hopes for first chikungunya vaccine.
    Science. 2026;391:536-537.
    PubMed         Abstract available
    
    
30. ROMANOV A, Knappe GA, Ronsard L, Cottrell CA, et al
    DNA origami vaccines program antigen-focused germinal centers.
    Science. 2026;391:eadx6291.
    PubMed         Abstract available
    
    

    
    Vaccine

31. MA X, Jin L, Li J, Jin P, et al
    Long-term protection of an inactivated enterovirus type 71 vaccine against hand, foot, and mouth diseases in children: a modelling study.
    Vaccine. 2026;76:128286.
    PubMed         Abstract available
    
    
32. SMITH EA, Malhame M, Malvolti S, Voss G, et al
    Use cases for pan-sarbecovirus vaccines: a workshop report.
    Vaccine. 2026;76:128312.
    PubMed         Abstract available
    
    
33. KIM DH, Kim JC, Lee SH, Kim J, et al
    Efficacy of dual administration vaccine of recombinant Newcastle disease virus expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza and viscerotropic Velogenic Newcastle disease virus in broilers.
    Vaccine. 2026;76:128288.
    PubMed         Abstract available
    
    
34. MADSEN AMR, Schaltz-Buchholzer F, Trebbien R, Roring R, et al
    Evaluating the non-specific effects of BCG vaccination on the immune system and serological response to influenza vaccination in the elderly: A randomised controlled trial.
    Vaccine. 2026;76:128305.
    PubMed         Abstract available
    
    
35. KHAN S, McWhorter AR, Andrews DM, Underwood GJ, et al
    Corrigendum to "An enhanced vaccination regime reduces the shedding of Salmonella Typhimurium from layer chickens" [Vaccine 72 (2026) 128115].
    Vaccine. 2026;76:128260.
    PubMed        
    
    
36. YOKOYAMA Y, Yao S, Cozza R, Gil F, et al
    A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged mice.
    Vaccine. 2026;74:128189.
    PubMed         Abstract available
    
    
37. HOBBS M, Marek L, Wiki J, Paynter J, et al
    Examining spatial variation and inequity in COVID-19 immunisation coverage in Aotearoa New Zealand: a nationwide geospatial study.
    Vaccine. 2026;74:128165.
    PubMed         Abstract available
    
    
38. CHOI Y, Choi IJ, Shim DH, Cha HR, et al
    Microneedle array patch delivery of Shigella flexneri 2a GMMA.
    Vaccine. 2026;74:128221.
    PubMed         Abstract available
    
    
39. EMBERS ME, Hasenkampf NR, Tardo AC, Timofeyeva Y, et al
    Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease.
    Vaccine. 2026;75:128231.
    PubMed         Abstract available
    
    
40. LIAO Z, Wu M, Chen Y, Zhu Z, et al
    Single-dose mSEB-mi3 nanoparticle vaccine elicits robust humoral immunity and protects mice against SEB intoxication and MRSA infection.
    Vaccine. 2026;75:128245.
    PubMed         Abstract available
    
    
41. CAI L, Fu Y, Li J, Wang X, et al
    Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib).
    Vaccine. 2026;75:128277.
    PubMed         Abstract available
    
    
42. HONG H, Eom TH, Lee E, Lee E, et al
    Immunological response of using emulsifying elongation factor 1 alpha of Plasmodium falciparum-based vaccines in complete Freund's adjuvant.
    Vaccine. 2026;75:128279.
    PubMed         Abstract available
    
    
43. ANDERSON SA, Smith ER, Wan Z, Amend KL, et al
    Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2-5 years.
    Vaccine. 2026;75:128225.
    PubMed         Abstract available
    
    
44. SAUVAGEAU C, Ionescu IG, Ouakki M, Panicker G, et al
    Long-term immunogenicity of alternative HPV vaccine schedules and the effect of an additional dose given three to five years post-primary vaccination.
    Vaccine. 2026;75:128287.
    PubMed         Abstract available
    
    
45. ALMEIDA ST, Paulo AC, Simoes AS, Handem S, et al
    Pneumococcal carriage and serotype distribution in Portuguese children six months after the lifting of COVID-19 restrictions: rise in serotype 3 amid stable non-vaccine serotypes.
    Vaccine. 2026;76:128294.
    PubMed         Abstract available
    
    
46. SHARMA AJ, Smoots AN, Madni SA, Zauche LH, et al
    COVID-19 vaccination during or just prior to pregnancy and hypertensive disorders of pregnancy.
    Vaccine. 2026;75:128268.
    PubMed         Abstract available
    
    
47. TONDEL C, Jenum S, Tonby K, Christensen EE, et al
    SARS-CoV-2T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trial.
    Vaccine. 2026;75:128290.
    PubMed         Abstract available
    
    
48. WANG K, Jordan T, Suzuki-Williams L, Qin J, et al
    Direct comparison of three herpes simplex virus-2 vaccine candidates using peripheral or mucosal routes of vaccination.
    Vaccine. 2026;75:128107.
    PubMed         Abstract available
    
    
49. KENEALY T, Aguirre-Duarte N, Roxburgh RH, Royle G, et al
    Accuracy of ICD and SNOMED search strategies for adverse events following COVID-19 vaccination: Analysis of hospital administrative data.
    Vaccine. 2026;75:128275.
    PubMed         Abstract available
    
    
50. POLAND GA, Ratishvili T, Pitts PJ
    COVID-19 vaccine policy: a response and way forward.
    Vaccine. 2026;75:128292.
    PubMed        
    
    
51. PARK IY, Cantu-Aldana A, Grafft N, Lo BK, et al
    Fathers' reports of within-household vaccine decision making and young children's COVID-19 vaccination status.
    Vaccine. 2026;75:128282.
    PubMed         Abstract available
    
    
52. CASSIE D, Komlenovic V, Parrera G, Drobic B, et al
    A phase 4, open-label, single arm, multi-center study to evaluate the safety of a smallpox vaccine in previously vaccinated individuals.
    Vaccine. 2026;75:128289.
    PubMed         Abstract available
    
    
53. CHELIOTIS KS, Gonzalez-Dias P, German EL, Goncalves ANA, et al
    Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.
    Vaccine. 2026;75:128280.
    PubMed         Abstract available
    
    
54. PASIK K, Iwan E, Bomba A, Blicharz KD, et al
    HTS-based control of Salmonella Enteritidis vaccines for chickens - pilot study.
    Vaccine. 2026;75:128297.
    PubMed         Abstract available
    
    
55. WITTENAUER R, Shah PD, Bacci JL, Mooney SJ, et al
    Pharmacy access and shingles vaccinations in the US: a propensity score matching analysis.
    Vaccine. 2026;75:128256.
    PubMed         Abstract available
    
    
56. THAKKAR K, Kefalogianni R, Zhang J, Yung CF, et al
    Clinical and economic benefits of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for prevention of RSV illness in infants: A cost-effectiveness analysis for Singapore.
    Vaccine. 2026;75:128285.
    PubMed         Abstract available
    
    
57. SAITO T, Couzinet A, Suzuki T, Shimomura M, et al
    Corrigendum to "Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms" [Vaccine 68 (2025) 127942].
    Vaccine. 2026;75:128267.
    PubMed        
    
    
58. BHUIYAN MU, Hernandez-Suarez G, Pilishvili T, Mayer B, et al
    Incidence and bacterial etiology of acute otitis media in children in the pneumococcal conjugate vaccine era: A systematic literature review and meta-analysis.
    Vaccine. 2026;75:128270.
    PubMed         Abstract available
    
    

    
    Virology

59. LI Z, Zhao M, Zhang G, Cheng J, et al
    Spike 1 trimer subunit vaccines against porcine epidemic diarrhea virus effectively induce protective immunity challenge in piglets.
    Virology. 2026;617:110823.
    PubMed         Abstract available
    
    
60. VADIBELER S, Mandal H, Ooi S, Atiya N, et al
    Barriers to dengue vaccine coverage in low- and middle-income countries (LMICs).
    Virology. 2026;617:110821.
    PubMed         Abstract available
    
    

    
    Virus Res

61. LUO X, Liu H, Kuang H, Xie Y, et al
    Impacts of Delayed Influenza Vaccination on Clinical Outcomes in ICU-Admitted Patients with Influenza: A Retrospective Cohort Study.
    Virus Res. 2026 Feb 3:199700. doi: 10.1016/j.virusres.2026.199700.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum